Vanessa Pereira

发表

Mechanistic Insights into Light-Driven Allosteric Control of GPCR Biological Activity.

Alice E. Berizzi, C. Goudet, X. Rovira, 2020, ACS pharmacology & translational science.

Role of the TREK2 potassium channel in cold and warm thermosensation and in pain perception

A. Eschalier, M. Lazdunski, J. Busserolles, 2014, PAIN®.

Synthesis and structure-activity relationship study of substituted caffeate esters as antinociceptive agents modulating the TREK-1 channel.

A. Eschalier, J. Busserolles, F. Lesage, 2014, European journal of medicinal chemistry.

Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin

D. A. Barrière, A. Eschalier, M. Lazdunski, 2018, Neuropharmacology.

Emerging Trends in Understanding Chemotherapy-Induced Peripheral Neuropathy

J. Busserolles, D. Balayssac, N. Authier, 2013, Current Pain and Headache Reports.

Synergistic regulation of serotonin and opioid signaling contributes to pain insensitivity in Nav1.7 knockout mice

J. Wood, Vanessa Pereira, K. Moeller, 2017, Science Signaling.

Activation of TREK-1 by morphine results in analgesia without adverse side effects

A. Eschalier, M. Lazdunski, J. Busserolles, 2013, Nature Communications.

Emerging Trends in Pain Modulation by Metabotropic Glutamate Receptors

C. Goudet, Vanessa Pereira, 2019, Front. Mol. Neurosci..

Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7

Flavia Mancini, John N. Wood, Vanessa Pereira, 2015, Nature Communications.

The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice

D. A. Barrière, A. Eschalier, J. Busserolles, 2021, International journal of molecular sciences.

Analgesia linked to Nav1.7 loss of function requires µ- and δ-opioid receptors

C. Gaveriaux-Ruff, J. Aramburu, J. Wood, 2018, Wellcome open research.

Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors

A. Eschalier, M. Lazdunski, J. Busserolles, 2011, EMBO molecular medicine.

A novel human pain insensitivity disorder caused by a point mutation in ZFHX2

A. Aloisi, Y. Komine, T. Yamamori, 2017, Brain : a journal of neurology.

Epigenetics Involvement in Oxaliplatin-Induced Potassium Channel Transcriptional Downregulation and Hypersensitivity

A. Eschalier, J. Busserolles, D. Balayssac, 2021, Molecular Neurobiology.

Distinct transcriptional responses of mouse sensory neurons in models of human chronic pain conditions

J. Cox, J. Wood, F. ter Heegde, 2018, Wellcome open research.

Analgesia linked to Nav1.7 loss of function requires μ and δ opioid receptors

J. Aramburu, J. Wood, C. López-Rodríguez, 2018, bioRxiv.

Inhibition of somatosensory mechanotransduction by annexin A6

M. Collins, J. Choudhary, E. Henckaerts, 2018, Science Signaling.

Photopharmacological manipulation of amygdala metabotropic glutamate receptor mGlu4 alleviates neuropathic pain.

C. Goudet, A. Llebaria, Vanessa Pereira, 2022, Pharmacological research.

Differential reduction of neuropathic pain symptoms by mGlu4-mediated neuromodulation of amygdala circuits

C. Goudet, A. Llebaria, Vanessa Pereira, 2022, bioRxiv.

Activation of TREK-1 by morphine results in analgesia without adverse side effects

A. Eschalier, M. Lazdunski, J. Busserolles, 2013, Nature Communications.

Epigenetics mechanisms and chronic pain

J. Busserolles, D. Balayssac, J. Ferrier, 2013 .